Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Luke J. Laffin

Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland

Branko Kopjar

Department of Health Systems and Population Health, University of Washington, Seattle

Carrie Melgaard

Cleveland Clinic Coordinating Center for Clinical Research, Cleveland

Kathy Wolski

Cleveland Clinic Coordinating Center for Clinical Research, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland

Jessica Ibbitson

Mineralys Therapeutics, Radnor, Pennsylvania

Shivani Bhikam

Mineralys Therapeutics, Radnor, Pennsylvania

Matthew R. Weir

Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore

Elizabeth O. Ofili

Department of Medicine, Morehouse School of Medicine, Atlanta

Reena Mehra

Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle

James M. Luther

Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville

Debbie L. Cohen

Division of Renal-Electrolyte and Hypertension, Department of Medicine, University of Pennsylvania, Philadelphia

Ashish Sarraju

Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland

Michael J. Wilkinson

Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla

John M. Flack

Departments of Medicine and Population Science and Policy, Division of General Internal Medicine, Hypertension Section, Southern Illinois University, Springfield

David Rodman

Mineralys Therapeutics, Radnor, Pennsylvania

Steven E. Nissen

Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland